Recent News

 Cost, technology issues are barriers to real-time cancer patient symptom reporting

Cost, technology issues are barriers to real-time cancer patient symptom reporting

In a perspective published in the New England Journal of Medicine, UNC Lineberger member Ethan Basch addressed the need for – and the barriers preventing – electronic reporting of patients’ symptoms between visits.

Cost, technology issues are barriers to real-time cancer patient symptom reporting - Read More…

Start-up with UNC ties secures $2.9 million to develop blood test for cancer

A start-up company co-founded by UNC Lineberger researcher Andrew Wang has raised $2.9 million to commercialize a test designed to capture cancer cells circulating in the blood.

Start-up with UNC ties secures $2.9 million to develop blood test for cancer - Read More…

Inside the world of cell signaling: a G-protein breakthrough

Inside the world of cell signaling: a G-protein breakthrough

Scientists led by UNC Lineberger member John Sondek, PhD, created a new biochemical tool to block specific types of downstream G-protein signaling, opening new avenues of research and potential drug design and discovery.

Inside the world of cell signaling: a G-protein breakthrough - Read More…

In blood of patients treated for other cancers, researchers find genetic precursors of leukemia

In blood of patients treated for other cancers, researchers find genetic precursors of leukemia

In a study presented at the American Society of Hematology Annual Meeting in San Diego, researchers found that nearly a quarter of patients heavily treated for other cancers had mutations in their white blood cells, and that the majority of those mutations were leukemia-linked.

In blood of patients treated for other cancers, researchers find genetic precursors of leukemia - Read More…